e-learning
resources
Paris 2018
Monday, 17.09.2018
Molecular mechanisms and treatment of pulmonary hypertension
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Late Breaking Abstract - Infrared thermography on patients with Pulmonary Hypertension. Prognostic value.
N. Atamañuk (Buenos Aires, Argentina), E. Calegari (Buenos Aires, Argentina), D. Litewka (Buenos Aires, Argentina), R. Zaug Nadur (Buenos Aires, Argentina), D. Hoffmann (Buenos Aires, Argentina), B. Mangarielo (Buenos Aires, Argentina), P. Guitelman (Buenos Aires, Argentina), M. Payaslian (Buenos Aires, Argentina)
Source:
International Congress 2018 – Molecular mechanisms and treatment of pulmonary hypertension
Session:
Molecular mechanisms and treatment of pulmonary hypertension
Session type:
Oral Presentation
Number:
3278
Disease area:
Pulmonary vascular diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
N. Atamañuk (Buenos Aires, Argentina), E. Calegari (Buenos Aires, Argentina), D. Litewka (Buenos Aires, Argentina), R. Zaug Nadur (Buenos Aires, Argentina), D. Hoffmann (Buenos Aires, Argentina), B. Mangarielo (Buenos Aires, Argentina), P. Guitelman (Buenos Aires, Argentina), M. Payaslian (Buenos Aires, Argentina). Late Breaking Abstract - Infrared thermography on patients with Pulmonary Hypertension. Prognostic value.. 3278
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Impact of Dexamethasone on pathogen profile of COVID-19 patients requiring intensive care: a multicentre retrospective study
Muscle energy techniques for COPD patients: Effects on pulmonary function and activities of daily living
Related content which might interest you:
Late Breaking Abstract - Covid-19 management in an Italian Prison. Monitoring of pulmonary function using oscillometry.
Source: Virtual Congress 2021 – Lung function evaluation and assessment of airway diseases
Year: 2021
Late Breaking Abstract - Assessment of disease progression in IPF patients using Functional Respiratory Imaging (FRI)
Source: International Congress 2017 – Idiopathic pulmonary fibrosis (IPF): clinical problems
Year: 2017
Late Breaking Abstract - Development of an animal model for group 3 Pulmonary Hypertension
Source: International Congress 2018 – Molecular mechanisms and treatment of pulmonary hypertension
Year: 2018
Late Breaking Abstract - Lung ultrasound for severity assessment and outcome prediction of COVID-19 patients.
Source: Virtual Congress 2020 – Transthoracic and endobronchial ultrasound
Year: 2020
Late Breaking Abstract - Arterial Stiffness and Cardiovascular Risk in hospitalised COPD patients
Source: International Congress 2019 – Imaging of airway diseases
Year: 2019
Late Breaking Abstract - Clinical Efficacy and Safety of Macitentan Transitioned from Bosentan in Patients with Pulmonary Arterial Hypertension
Source: International Congress 2018 – Molecular mechanisms and treatment of pulmonary hypertension
Year: 2018
PP219 – Development and Validation of a Novel Prognostic Nomogram for COPD patients with Pulmonary Hypertension
Source: ERS Lung Science Conference 2021
Year: 2021
Late Breaking Abstract - Long-term Effect of Pulmonary Rehabilitation under Nintedanib treatment in Idiopathic Pulmonary Fibrosis (FITNESS study)
Source: Virtual Congress 2021 – ALERT: Asthma in adult, in children and ILDs
Year: 2021
Late Breaking Abstract - Chest radiography-a predictor of prognosis in COVID-19
Source: Virtual Congress 2020 – Imaging-based phenotyping in pulmonary disease
Year: 2020
Late Breaking Abstract - Bronchoscopic Thermal Vapor Ablation (BTVA) Outcomes at 12 months in Emphysema Patients with Severe Hyperinflation, a STEP-UP RCT Subgroup Analysis
Source: International Congress 2017 – Late-breaking findings in asthma and COPD
Year: 2017
Late Breaking Abstract - Pulmonary embolism in patients admitted by COVID-19. Incidence and features.
Source: Virtual Congress 2020 – Right ventricular function and pulmonary hypertension
Year: 2020
Late Breaking Abstract - Balloon Pulmonary Angioplasty for the Treatment of Non Operable Chronic Thromboembolic Pulmonary Hypertension – Initial experience of a Belgian Center
Source: International Congress 2018 – Chronic thromboembolic pulmonary hypertension
Year: 2018
Prognostic value of outcome variables at follow-up in patients with PAH
Source: International Congress 2014 – Chronic thromboembolic pulmonary hypertension
Year: 2014
Late Breaking Abstract - Detection of clinical instability by eNose in COPD patients
Source: International Congress 2018 – How far are we in terms of predicting mortality and exacerbations in COPD?
Year: 2018
Late Breaking Abstract - Influence of Weather Conditions on the Onset of Primary Spontaneous Pneumothorax: Positive Association with Occurrence of “clusters”
Source: International Congress 2017 – Late-breaking studies in pulmonary diseases
Year: 2017
Late Breaking Abstract - Endobronchial Valves for Severe Emphysema – 12-month Results of the EMPROVE Trial
Source: International Congress 2018 – Interventional pulmonology highlights in 2018: ELVR, TLD and BT
Year: 2018
Late Breaking Abstract - A Deep Learning Algorithm for Classifying Fibrotic Lung Disease on High Resolution Computed Tomography
Source: International Congress 2018 – ILDs: From bench to bedside
Year: 2018
Late Breaking Abstract - SUPRAnav: A Clinical Trial Evaluating the Efficacy and Safety of a New Invention Device Designed for Continuous Supraglottic Aspiration in Mechanically Ventilated Patients.
Source: International Congress 2019 – ALERT: Abstracts Leading to Evolution in Respiratory Medicine Trials: Intensive care and infection
Year: 2019
Late Breaking Abstract - CPAnet Registry – An International Chronic Pulmonary Aspergillosis Registry
Source: Virtual Congress 2020 – Airway infection: the microbiome and beyond
Year: 2020
Late Breaking Abstract - Pulmonary embolism in patients with COVID-19: Time to change thromboprophylaxis paradigm.
Source: Virtual Congress 2020 – Right ventricular function and pulmonary hypertension
Year: 2020
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept